Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery
We report the survival of consecutive patients with borderline resectable pancreatic cancer who received neoadjuvant therapy before surgery.
Source: Surgery - Category: Surgery Authors: Chad A. Barnes, Mariana I. Chavez, Susan Tsai, Mohammed Aldakkak, Ben George, Paul S. Ritch, Kulwinder Dua, Callisia N. Clarke, Parag Tolat, Catherine Hagen, William A. Hall, Beth A. Erickson, Douglas B. Evans, Kathleen K. Christians Source Type: research
More News: Cancer | Cancer & Oncology | Chad Health | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Surgery